Skip to main content
Clinical Trials/IRCT20220322054341N2
IRCT20220322054341N2
Recruiting
Phase 2

Comparison of the therapeutic effect of the combination of Erbium YAG laser and stromal vascular fraction (SVF), the combination of Erbium YAG laser and platelet-rich plasma (PRP) and Erbium YAG laser alone in the treatment of striae

Skin and Stem Cell Research Center of Tehran University of Medical Sciences0 sites10 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
striae distensae.
Sponsor
Skin and Stem Cell Research Center of Tehran University of Medical Sciences
Enrollment
10
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Skin and Stem Cell Research Center of Tehran University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • The diagnosis of stria distensa based on the diagnosis of a dermatologist
  • Age less than 50 years and more than 18 years

Exclusion Criteria

  • Using any treatment method to remove striae in the last three months
  • Presence of lesions and skin diseases such as skin cancer or infections
  • Presence of collagen vascular diseases
  • Pregnancy and lactation
  • Using steroids or immunosuppressive drugs

Outcomes

Primary Outcomes

Not specified

Similar Trials